General Information of the Protein
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein Protein Cell Line Compound Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000059 , HuT 78
Biochemical Assays
Clinical Information about the Protein
Target 1 ( Bromodomain-containing protein 2 (BRD2) )
Target Type | Clinical trial Target | ||||
---|---|---|---|---|---|
Disease | 2 Target-related Diseases | 2 | |||
1 | Prostate cancer [ICD-11: 2C82.0] | ||||
2 | Acute myeloid leukaemia [ICD-11: 2A60] | ||||
Clinical Trial Drug(s) | 2 Clinical Trial Drugs | 2 | |||
1 | ABBV-744 | Phase 1 | |||
2 | OTX-015 | Phase 1/2 |
Target 2 ( HUMAN bromodomain-containing protein 2 (BRD2) )
Target Type | Unknown Type Target | ||||
---|---|---|---|---|---|
Disease | 1 Target-related Disease | 1 | |||
1 | Coronavirus Disease 2019 (COVID-19) [ICD-11: 1D6Y] | ||||
Investigative Drug(s) | 2 Investigative Drugs | 2 | |||
1 | ABBV-744 | Investigative | |||
2 | JQ1 | Investigative |